Acadia Healthcare sentiment likely to worsen further, says Cantor Fitzgerald

Acadia Healthcare’s (ACHC) Q3 results disappointed, with FY25 EBITDA guidance cut by 5% and additional negative surprises weighing on sentiment, Cantor Fitzgerald tells investors in a research note. While a guidance reduction was expected after the September preannouncement, higher bad debt, legal costs, and ongoing volume pressures further dampened outlook, the firm says. Cantor has a Neutral rating and $25 price target on the stock.